TrialHIV medicine2015

Reported consent processes and demographics: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

E Denning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.